Adagio medical announces participation in the 19th annual international symposium on ventricular arrhythmias

Laguna hills, calif.--(business wire)--adagio medical holdings, inc. (nasdaq: adgm; the “company”), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced its sponsorship and participation in the 19th annual international symposium on ventricular arrhythmias, to be held at the new york marriott at the brooklyn bridge on october 11-12, 2024. in addition to participating in the commercial exhibition, adagio's proprietary ultra-low temperature c.
ADGM Ratings Summary
ADGM Quant Ranking